Search

Author/Creator Jeng, Hao-Hsuan

1. A Postmarketing Surveillance Study on Erbitux (Cetuximab) in Patients With Metastatic Colorectal Cancer Refractory to Irinotecan-Containing Treatment. (1st October 2013)

Authors:
Huang, Wen-Tsung; Chen, Hong-Hwa; Yeh, Chung-Hung; Lu, Yin-Che; Hwang, Wei-Shou; Huang, Jen-Seng; Chen, Chou-Pin; Lin, Peng-Chan; Uen, Wu-Ching; Lee, Yang-Cheng; Wang, Hwei-Ming; Wu, Hong-Cheng; Chen, Jinn-Shiun; Kao, Ruey-Ho; Huang, Chi-Chou; Jeng, Hao-Hsuan; Lin, Chia-Jung; Hsieh, Ruey-Kuen
Journal:
Journal of investigative medicine
Issue:
Volume 61:Number 7(2013)
Page Start:
1108
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Postmarketing Surveillance Study on Erbitux (Cetuximab) in Patients with Metastatic Colorectal Cancer Refractory to Irinotecan-Containing Treatment. (October 2013)

Authors:
Huang, Wen-Tsung; Chen, Hong-Hwa; Yeh, Chung-Hung; Lu, Yin-Che; Hwang, Wei-Shou; Huang, Jen-Seng; Chen, Chou-Pin; Lin, Peng-Chan; Uen, Wu-Ching; Lee, Yang-Cheng; Wang, Hwei-Ming; Wu, Hong-Cheng; Chen, Jinn-Shiun; Kao, Ruey-Ho; Huang, Chi-Chou; Jeng, Hao-Hsuan; Lin, Chia-Jung; Hsieh, Ruey-Kuen
Journal:
Journal of investigative medicine
Issue:
Volume 61:Number 7(2013)
Page Start:
1108
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search